病毒组:超越疫苗的可能性
Hadeel K Salameh1, Mohammed M Safi1, Rafik Karaman1,2
1Pharmaceutical Sciences Department, Faculty of Pharmacy, Al-Quds University, Jerusalem 20002, Palestine.
Life (Basel, Switzerland)
|October 29, 2025
概括
病毒体,一种新的疫苗输送系统,有效触发强烈的免疫反应. 这些先进的结构利用病毒包裹或重组方法来增强免疫性,为未来的疫苗创新铺平了道路.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 疫苗接种对于预防传染病至关重要,需要强大的幽默和细胞免疫力.
- 像脂质体和纳米凝这样的创新疫苗输送系统可以增强免疫性.
- 针对难以改变的蛋白质需要先进的传递策略.
研究的目的:
- 为了检查病毒体作为一个尖端的疫苗输送系统.
- 探索病毒体在引起复杂免疫反应方面的潜力.
- 审查病毒体的开发,制造和未来前景.
主要方法:
- 在PubMed,ScienceDirect和Google Scholar进行的文献搜索.
- 关键词包括"病毒体"",血凝素"和"IRIV"用于文章选择.
- 对病毒体结构和免疫原性质的分析.
主要成果:
- 病毒体是药品和疫苗的有效输送系统.
- 他们利用非活化的病毒包裹或重组方法来模仿病毒结构.
- 病毒体的结构特征刺激强烈的免疫反应.
结论:
- 病毒组代表了疫苗技术的重大进步.
- 这篇文章提供了历史概述,并讨论了制造技术.
- 突出了医学中病毒体革命的未来潜力.
相关概念视频
Vaccinations
51.2K
Overview
51.2K
Immune Response Against Viral Pathogens
1.7K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.7K
Microorganisms in Medicine and Therapeutics
928
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
928
Viral Mutations
39.6K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.6K
Retroviruses
14.6K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
14.6K
Retrovirus Life Cycles
49.2K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.2K


